Drugs that contain Paliperidone Palmitate

1. Drug name - INVEGA HAFYERA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10143693 JANSSEN PHARMS Dosing regimen for missed doses for long-acting injectable paliperidone esters Apr, 2036

(13 years from now)

Treatment: Reinitiation of schizophrenia treatment following a missed dose more than 9 months ago; reinitiation of schizophrenia treatment following a missed dose 4-9 months ago

Dosage: SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

More Information on Dosage
Strength Dosage Availability
1.092GM/3.5ML (312MG/ML) SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription
1.560GM/5ML (312MG/ML) SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription
273MG/0.875ML (273MG/0.875ML) SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription
410MG/1.315ML (311.79MG/ML) SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription
546MG/1.75ML (312MG/ML) SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription
819MG/2.625ML (312MG/ML) SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription

2. Drug name - INVEGA SUSTENNA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9439906 JANSSEN PHARMS Dosing regimen associated with long acting injectable paliperidone esters Jan, 2031

(8 years from now)

Treatment: Treatment of schizophrenia; treatment of schizoaffective disorder as a monotherapy and as an adjunct to mood stabilizers or antidepressants; dosing regimen for the treatment of schizoaffective disorder in adults as a monotherapy and as an adjunct to mood stabilizers or antidepressants by administering two loading doses of paliperidone palmitate followed by maintenance dose(s); dosing regimen for the treatment of schizophrenia in adults by administering two loading doses of paliperidone palmitate followed by maintenance dose(s)

Dosage: SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

More Information on Dosage
Strength Dosage Availability
39MG/0.25ML (39MG/0.25ML) SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription
78MG/0.5ML (78MG/0.5ML) SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription
117MG/0.75ML (117MG/0.75ML) SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription
156MG/ML (156MG/ML) SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription
234MG/1.5ML (156MG/ML) SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR Prescription

availability in other generic markets.

Click on the highlighted region to filter.